Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes

By R. Cristescu, Jeeyun Lee, M. Nebozhyn, Kyoung-Mee Kim, Jason C. Ting, S. Wong, Jiangang Liu, Y. Yue, Jian Wang, Kun Yu and 24 more. Nature Medicine, 2015

1,961 citations recorded by the source corpus.

Subfields: Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/4c30e5c97b30d984cf51d50415052ff18cdd94e0

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. F. Bibeau
2. C. Luchini
3. M. Ligtenberg
4. Naveena Singh
5. A. Nottegar
6. T. Bosse
7. R. Miller
8. J. Douillard

Citations in the corpus

• ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach. (2019, background): “Recommendation B. MSI-PCR molecular testing is indicated in case of indeterminate IHC results, including disagreement or difficulties in interpreting IHC or in the case of loss of only one heterodimer subunit (e.g. only MLH1 or only PMS2 and not both).”